Tollenaar RA - Search Results

Save citations to file

Email citations

Your saved search

Your RSS Feed

Page 1

Low penetrance breast cancer susceptibility loci are associated with specific breast tumor subtypes: findings from the Breast Cancer Association Consortium.

Broeks A, Schmidt MK, Sherman ME, Couch FJ, Hopper JL, Dite GS, Apicella C, Smith LD, Hammet F, Southey MC, Van 't Veer LJ, de Groot R, Smit VT, Fasching PA, Beckmann MW, Jud S, Ekici AB, Hartmann A, Hein A, Schulz-Wendtland R, Burwinkel B, Marme F, Schneeweiss A, Sinn HP, Sohn C, Tchatchou S, Bojesen SE, Nordestgaard BG, Flyger H, Ørsted DD, Kaur-Knudsen D, Milne RL, Pérez JI, Zamora P, Rodríguez PM, Benítez J, Brauch H, Justenhoven C, Ko YD; Genica Network; Hamann U, Fischer HP, Brüning T, Pesch B, Chang-Claude J, Wang-Gohrke S, Bremer M, Karstens JH, Hillemanns P, Dörk T, Nevanlinna HA, Heikkinen T, Heikkilä P, Blomqvist C, Aittomäki K, Aaltonen K, Lindblom A, Margolin S, Mannermaa A, Kosma VM, Kauppinen JM, Kataja V, Auvinen P, Eskelinen M, Soini Y, Chenevix-Trench G, Spurdle AB, Beesley J, Chen X, Holland H; kConFab; AOCS; Lambrechts D, Claes B, Vandorpe T, Neven P, Wildiers H, Flesch-Janys D, Hein R, Löning T, Kosel M, Fredericksen ZS, Wang X, Giles GG, Baglietto L, Severi G, McLean C, Haiman CA, Henderson BE, Le Marchand L, Kolonel LN, Alnæs GG, Kristensen V, Børresen-Dale AL, Hunter DJ, Hankinson SE, Andrulis IL, Mulligan AM, O'Malley FP, Devilee P, Huijts PE, Tollenaar… See abstract for full author list ➔ Broeks A, et al. Among authors: tollenaar ra. Hum Mol Genet. 2011 Aug 15;20(16):3289-303. doi: 10.1093/hmg/ddr228. Epub 2011 May 19. Hum Mol Genet. 2011. PMID: 21596841 Free PMC article.

2

Prevalence of BRCA1 in a hospital-based population of Dutch breast cancer patients.
Papelard H, de Bock GH, van Eijk R, Vliet Vlieland TP, Cornelisse CJ, Devilee P, Tollenaar RA. Papelard H, et al. Among authors: tollenaar ra. Br J Cancer. 2000 Sep;83(6):719-24. doi: 10.1054/bjoc.2000.1331. Br J Cancer. 2000. PMID: 10952774 Free PMC article.

3

[From gene to disease; from BRCA1 or BRCA2 to breast cancer].
Devilee P, Tollenaar RA, Cornelisse CJ. Devilee P, et al. Among authors: tollenaar ra. Ned Tijdschr Geneeskd. 2000 Dec 30;144(53):2549-51. Ned Tijdschr Geneeskd. 2000. PMID: 11191790 Review. Dutch.

4

Clinical and pathological features of BRCA1 associated carcinomas in a hospital-based sample of Dutch breast cancer patients.
de Bock GH, Tollenaar RA, Papelard H, Cornelisse CJ, Devilee P, van de Vijver MJ. de Bock GH, et al. Among authors: tollenaar ra. Br J Cancer. 2001 Nov 2;85(9):1347-50. doi: 10.1054/bjoc.2001.2103. Br J Cancer. 2001. PMID: 11720473 Free PMC article.

5

Genetic counselling and the intention to undergo prophylactic mastectomy: effects of a breast cancer risk assessment.
van Dijk S, Otten W, Zoeteweij MW, Timmermans DR, van Asperen CJ, Breuning MH, Tollenaar RA, Kievit J. van Dijk S, et al. Among authors: tollenaar ra. Br J Cancer. 2003 Jun 2;88(11):1675-81. doi: 10.1038/sj.bjc.6600988. Br J Cancer. 2003. PMID: 12771979 Free PMC article.

6

Possible consequences of applying guidelines to healthy women with a family history of breast cancer.
van Asperen CJ, Tollenaar RA, Krol-Warmerdam EM, Blom J, Hoogendoorn WE, Seynaeve CM, Brekelmans CT, Devilee P, Cornelisse CJ, Klijn JG, de Bock GH. van Asperen CJ, et al. Among authors: tollenaar ra. Eur J Hum Genet. 2003 Aug;11(8):633-6. doi: 10.1038/sj.ejhg.5201021. Eur J Hum Genet. 2003. PMID: 12891386

7

[Genetic research with stored human tissue: a coding procedure with optimal use of information and protection of privacy].
Schmidt MK, van Leeuwen FE, Klaren HM, Tollenaar RA, van 't Veer LJ. Schmidt MK, et al. Among authors: tollenaar ra. Ned Tijdschr Geneeskd. 2004 Mar 20;148(12):564-8. Ned Tijdschr Geneeskd. 2004. PMID: 15074178 Review. Dutch.

8

Tumour characteristics and prognosis of breast cancer patients carrying the germline CHEK2*1100delC variant.
de Bock GH, Schutte M, Krol-Warmerdam EM, Seynaeve C, Blom J, Brekelmans CT, Meijers-Heijboer H, van Asperen CJ, Cornelisse CJ, Devilee P, Tollenaar RA, Klijn JG. de Bock GH, et al. Among authors: tollenaar ra. J Med Genet. 2004 Oct;41(10):731-5. doi: 10.1136/jmg.2004.019737. J Med Genet. 2004. PMID: 15466005 Free PMC article.

9

Risk reduction of contralateral breast cancer and survival after contralateral prophylactic mastectomy in BRCA1 or BRCA2 mutation carriers.
van Sprundel TC, Schmidt MK, Rookus MA, Brohet R, van Asperen CJ, Rutgers EJ, Van't Veer LJ, Tollenaar RA. van Sprundel TC, et al. Among authors: tollenaar ra. Br J Cancer. 2005 Aug 8;93(3):287-92. doi: 10.1038/sj.bjc.6602703. Br J Cancer. 2005. PMID: 16052221 Free PMC article.

10

Efficacy of screening women at high risk of hereditary ovarian cancer: results of an 11-year cohort study.
Gaarenstroom KN, van der Hiel B, Tollenaar RA, Vink GR, Jansen FW, van Asperen CJ, Kenter GG. Gaarenstroom KN, et al. Among authors: tollenaar ra. Int J Gynecol Cancer. 2006 Jan-Feb;16 Suppl 1:54-9. doi: 10.1111/j.1525-1438.2006.00480.x. Int J Gynecol Cancer. 2006. PMID: 16515568

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

466 results

Search Page

Filters